osm (R&D Systems)
95
Structured Review
R&D Systems
osm
Osm, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 144 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+osm/Recombinant+Human+Oncostatin+M+(OSM)+Protein/pm41986711-647-160-164
Average 95 stars, based on 144 article reviews
Osm, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 144 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+osm/Recombinant+Human+Oncostatin+M+(OSM)+Protein/pm41986711-647-160-164
Average 95 stars, based on 144 article reviews
osm - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Recombinant:Article Title: Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching Article Snippet: Cells were stimulated with recombinant human OSM (100 ng/mL, R&D Systems) for 1, 3, 6, and 24 h, and gene expression changes analyzed by RT-qPCR (Section 2.9). .. In addition, cells were stimulated with various concentrations of recombinant Article Title: Widely targeted metabolomics analysis of different parts of kudzu. Article Snippet: Breast cancer cells frequently home to the bone marrow, where they encounter signals that promote survival and quiescence or stimulate their proliferation.. The interleukin-6 (IL-6) cytokines signal through the co-receptor glycoprotein130 (gp130) and are abundantly secreted within the bone microenvironment.. Breast cancer cell expression of leukemia inhibitory factor (LIF) receptor (LIFR)/ STAT3 signaling promotes tumor dormancy in the bone, but it is unclear which, if any of the cytokines that signal through LIFR, including LIF, oncostatin M (OSM), and ciliary neurotrophic factor (CNTF), promote tumor dormancy and which signaling pathways are induced. Article Title: Biophysical and Biochemical Regulation of Cell Dynamics in Magnetically Assembled Cellular Structures Article Snippet: .. After 24 h incubation, the cells were exposed to either 25 mM Gadavist or regular KSFM (control) for 3 h. Subsequently, the wells were rinsed, and cells were exposed to recombinant Article Title: Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching Article Snippet: The keratinocyte cell line Human Epidermal Keratinocytes, pooled (HEK) was obtained from Gibco (Gibco ThermoFisher, NY, USA) and cultured in Keratinocyte SFM (Gibco ThermoFisher) supplemented with 5 μg/mL human recombinant epidermal growth factor (Gibco ThermoFisher), 50 μg/mL bovine pituitary extract (Gibco ThermoFisher), and 100 IU/mL penicillin/streptomycin (Gibco ThermoFisher). .. Cells were stimulated with recombinant Gene Expression:Article Title: Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching Article Snippet: Cells were stimulated with recombinant human OSM (100 ng/mL, R&D Systems) for 1, 3, 6, and 24 h, and gene expression changes analyzed by RT-qPCR (Section 2.9). .. In addition, cells were stimulated with various concentrations of recombinant Article Title: Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching Article Snippet: The keratinocyte cell line Human Epidermal Keratinocytes, pooled (HEK) was obtained from Gibco (Gibco ThermoFisher, NY, USA) and cultured in Keratinocyte SFM (Gibco ThermoFisher) supplemented with 5 μg/mL human recombinant epidermal growth factor (Gibco ThermoFisher), 50 μg/mL bovine pituitary extract (Gibco ThermoFisher), and 100 IU/mL penicillin/streptomycin (Gibco ThermoFisher). .. Cells were stimulated with recombinant Quantitative RT-PCR:Article Title: Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching Article Snippet: Cells were stimulated with recombinant human OSM (100 ng/mL, R&D Systems) for 1, 3, 6, and 24 h, and gene expression changes analyzed by RT-qPCR (Section 2.9). .. In addition, cells were stimulated with various concentrations of recombinant Article Title: Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching Article Snippet: The keratinocyte cell line Human Epidermal Keratinocytes, pooled (HEK) was obtained from Gibco (Gibco ThermoFisher, NY, USA) and cultured in Keratinocyte SFM (Gibco ThermoFisher) supplemented with 5 μg/mL human recombinant epidermal growth factor (Gibco ThermoFisher), 50 μg/mL bovine pituitary extract (Gibco ThermoFisher), and 100 IU/mL penicillin/streptomycin (Gibco ThermoFisher). .. Cells were stimulated with recombinant Control:Article Title: Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof Article Snippet: The isotype control and human OSM (hOSM; R&D Systems, #295-OM/CF) were half-log diluted (11 points) to final concentrations ranging from 100 nM to 1 pM in Assay Buffer and were then added to the cells. .. The isotype control and Article Title: Biophysical and Biochemical Regulation of Cell Dynamics in Magnetically Assembled Cellular Structures Article Snippet: .. After 24 h incubation, the cells were exposed to either 25 mM Gadavist or regular KSFM (control) for 3 h. Subsequently, the wells were rinsed, and cells were exposed to recombinant Incubation:Article Title: Biophysical and Biochemical Regulation of Cell Dynamics in Magnetically Assembled Cellular Structures Article Snippet: .. After 24 h incubation, the cells were exposed to either 25 mM Gadavist or regular KSFM (control) for 3 h. Subsequently, the wells were rinsed, and cells were exposed to recombinant Enzyme-linked Immunosorbent Assay:Article Title: Biophysical and Biochemical Regulation of Cell Dynamics in Magnetically Assembled Cellular Structures Article Snippet: .. After 24 h incubation, the cells were exposed to either 25 mM Gadavist or regular KSFM (control) for 3 h. Subsequently, the wells were rinsed, and cells were exposed to recombinant Article Title: Oncostatin M for characterizing the inflammatory burden and outcome of V-V ECMO in ARDS patients. Article Snippet: Venovenous extracorporeal membrane oxygenation (VV ECMO) has become increasingly important for supporting patients with refractory acute respiratory failure.1 Plasma lactate (pLA), a laboratory marker for tissue hypoxia and hypoperfusion,2 has been widely used to assess the anticipated outcome of ECMO support despite uncertainties about its reliability.3,4 However, potential markers that are more directly associated with the pathogenesis of acute respiratory failure itself have not been thoroughly investigated.. We hypothesized that plasma oncostatin M Received: 27 February 2023 | Revised: 11 July 2023 | Accepted: 14 July 2023 DOI: 10.1111/aor.14619 Clinical Proteomics:Article Title: Oncostatin M for characterizing the inflammatory burden and outcome of V-V ECMO in ARDS patients. Article Snippet: Venovenous extracorporeal membrane oxygenation (VV ECMO) has become increasingly important for supporting patients with refractory acute respiratory failure.1 Plasma lactate (pLA), a laboratory marker for tissue hypoxia and hypoperfusion,2 has been widely used to assess the anticipated outcome of ECMO support despite uncertainties about its reliability.3,4 However, potential markers that are more directly associated with the pathogenesis of acute respiratory failure itself have not been thoroughly investigated.. We hypothesized that plasma oncostatin M Received: 27 February 2023 | Revised: 11 July 2023 | Accepted: 14 July 2023 DOI: 10.1111/aor.14619 |